Skip to content
Home/Companies/Biotech/Gamamabs Pharma

Gamamabs Pharma

Biotech·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Gamamabs Pharma?

Gamamabs Pharma is currently owned by Irdi Capital-Investissement through IRDI Impulsion (2021 vintage), since 2021. Across its history, Gamamabs Pharma has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Irdi Capital-Investissement
Most recent investor
Irdi Capital-Investissement
IRDI Impulsion · 2021 · Buyout
2 ownership periods · full history below

Key facts

HQFrance
SectorBiotech

Ownership history

2 ownership periods · co-invest detected

Active
Co-invest · 2 holders · 2013 · present
iXO Private Equity
2013 · present(13yr) · FIP APL 2013 · 2013 · Growth
Irdi Capital-Investissement
2021 · present(5yr) · IRDI Impulsion · 2021 · Buyout
Track Gamamabs Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Gamamabs Pharma?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Gamamabs Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue